GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Price-to-Free-Cash-Flow

SER (Serina Therapeutics) Price-to-Free-Cash-Flow : N/A (As of Mar. 30, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Price-to-Free-Cash-Flow?

As of today (2025-03-30), Serina Therapeutics's share price is $5.29. Serina Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-2.14. Hence, Serina Therapeutics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Serina Therapeutics's Price-to-Free-Cash-Flow or its related term are showing as below:

SER's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.62
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Serina Therapeutics's Free Cash Flow per Share for the three months ended in Dec. 2024 was $-0.50. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-2.14.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -95.30% per year.

During the past 4 years, Serina Therapeutics's highest 3-Year average Free Cash Flow per Share Growth Rate was -95.30% per year. The lowest was -95.30% per year. And the median was -95.30% per year.


Serina Therapeutics Price-to-Free-Cash-Flow Historical Data

The historical data trend for Serina Therapeutics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Price-to-Free-Cash-Flow Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
- - - -

Serina Therapeutics Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Serina Therapeutics's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Serina Therapeutics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Serina Therapeutics's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's Price-to-Free-Cash-Flow falls into.


;
;

Serina Therapeutics Price-to-Free-Cash-Flow Calculation

Serina Therapeutics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=5.29/-2.139
=N/A

Serina Therapeutics's Share Price of today is $5.29.
Serina Therapeutics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Serina Therapeutics  (AMEX:SER) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Serina Therapeutics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Serina Therapeutics Business Description

Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.